Has Last Shoe Dropped in Fight Against Superbugs?
Resistance to drug of last resort—Carbapenem resistant bacteria—found for first time in U.S. livestock
Underscoring the potential public health threats widespread agricultural practices pose, bacteria resistant to a class of last-resort antibiotics known as carbapenems has for the first time been found on a U.S. pig farm.
The findings were published Monday in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology, and come just months after another antibiotic used as a last resort--colistin--was found in a pig in the U.S.
The Centers for Disease Control and Prevention has said Carbapenem-resistant Enterobacteriaceae (CREs), which are carried by a mobile piece of independent DNA called a plasmid, present an urgent public heath threat.
"It's a surprise that they would show up in livestock," said corresponding author, Thomas Wittum, professor and chair of Veterinary Preventive Medicine at Ohio State University.
An accompanying press statement notes that "[c]arbapenems are a subset of b-lactam antibiotics. B-lactam antibiotics which are not carbapenems are legal for use on farms in the U.S."
For the study, researchers took environmental and fecal samples during four visits over a five-month period from a 1,500-sow, farrow-to-finish pig farm which "followed typical U.S. production practices." Piglets in the farrowing area are given a dose of Ceftiofur--a b-lactam antibiotic--with males given a second dose.
The researchers said they were surprised at finding the few samples of the resistant gene, as it's a closed barn--no new animals had been introduced for five decades. So how did it get there? "We don't know," Wittum told HealthDay News.
Wittum added that the researchers found "no evidence the pigs carried the gene into the [human] food supply."
The authors conclude:
The implication of our finding is that there is a real risk that CRE may disseminate in food animal populations and eventually contaminate fresh retail meat products. Food-borne transmission may then produce a reservoir of mobile carbapenemase genes in the enteric flora of consumers.
The Natural Resources Defense Council (NRDC) said the findings were troubling.
"The last terrible shoe may have just dropped when it comes to drug-resistant infections," said Dr. David Wallinga, senior health officer at NRDC.
"This is just one more warning that doctors may soon have nothing left in their toolkit to save patients when these bugs strike. Our overuse of antibiotics in livestock is creating reservoirs for the spread of resistance--and this study strongly suggests resistance to carbapenems is no exception. To save our miracle drugs, we have got to stop wasting them on animals that aren't sick," Wallinga added.
In September, when world leaders gathered for a historic high-level meeting at the United Nations General Assembly to lay out how to fight so-called "superbugs"--Dr. Margaret Chan, Director-General of the World Health Organization, said, "Antimicrobial resistance poses a fundamental threat to human health, development, and security. The commitments made today must now be translated into swift, effective, lifesaving actions across the human, animal and environmental health sectors."
"We are running out of time," she warned.
FINAL DAY! This is urgent.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just hours left in our Spring Campaign, we're still falling short of our make-or-break goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
Underscoring the potential public health threats widespread agricultural practices pose, bacteria resistant to a class of last-resort antibiotics known as carbapenems has for the first time been found on a U.S. pig farm.
The findings were published Monday in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology, and come just months after another antibiotic used as a last resort--colistin--was found in a pig in the U.S.
The Centers for Disease Control and Prevention has said Carbapenem-resistant Enterobacteriaceae (CREs), which are carried by a mobile piece of independent DNA called a plasmid, present an urgent public heath threat.
"It's a surprise that they would show up in livestock," said corresponding author, Thomas Wittum, professor and chair of Veterinary Preventive Medicine at Ohio State University.
An accompanying press statement notes that "[c]arbapenems are a subset of b-lactam antibiotics. B-lactam antibiotics which are not carbapenems are legal for use on farms in the U.S."
For the study, researchers took environmental and fecal samples during four visits over a five-month period from a 1,500-sow, farrow-to-finish pig farm which "followed typical U.S. production practices." Piglets in the farrowing area are given a dose of Ceftiofur--a b-lactam antibiotic--with males given a second dose.
The researchers said they were surprised at finding the few samples of the resistant gene, as it's a closed barn--no new animals had been introduced for five decades. So how did it get there? "We don't know," Wittum told HealthDay News.
Wittum added that the researchers found "no evidence the pigs carried the gene into the [human] food supply."
The authors conclude:
The implication of our finding is that there is a real risk that CRE may disseminate in food animal populations and eventually contaminate fresh retail meat products. Food-borne transmission may then produce a reservoir of mobile carbapenemase genes in the enteric flora of consumers.
The Natural Resources Defense Council (NRDC) said the findings were troubling.
"The last terrible shoe may have just dropped when it comes to drug-resistant infections," said Dr. David Wallinga, senior health officer at NRDC.
"This is just one more warning that doctors may soon have nothing left in their toolkit to save patients when these bugs strike. Our overuse of antibiotics in livestock is creating reservoirs for the spread of resistance--and this study strongly suggests resistance to carbapenems is no exception. To save our miracle drugs, we have got to stop wasting them on animals that aren't sick," Wallinga added.
In September, when world leaders gathered for a historic high-level meeting at the United Nations General Assembly to lay out how to fight so-called "superbugs"--Dr. Margaret Chan, Director-General of the World Health Organization, said, "Antimicrobial resistance poses a fundamental threat to human health, development, and security. The commitments made today must now be translated into swift, effective, lifesaving actions across the human, animal and environmental health sectors."
"We are running out of time," she warned.
Underscoring the potential public health threats widespread agricultural practices pose, bacteria resistant to a class of last-resort antibiotics known as carbapenems has for the first time been found on a U.S. pig farm.
The findings were published Monday in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology, and come just months after another antibiotic used as a last resort--colistin--was found in a pig in the U.S.
The Centers for Disease Control and Prevention has said Carbapenem-resistant Enterobacteriaceae (CREs), which are carried by a mobile piece of independent DNA called a plasmid, present an urgent public heath threat.
"It's a surprise that they would show up in livestock," said corresponding author, Thomas Wittum, professor and chair of Veterinary Preventive Medicine at Ohio State University.
An accompanying press statement notes that "[c]arbapenems are a subset of b-lactam antibiotics. B-lactam antibiotics which are not carbapenems are legal for use on farms in the U.S."
For the study, researchers took environmental and fecal samples during four visits over a five-month period from a 1,500-sow, farrow-to-finish pig farm which "followed typical U.S. production practices." Piglets in the farrowing area are given a dose of Ceftiofur--a b-lactam antibiotic--with males given a second dose.
The researchers said they were surprised at finding the few samples of the resistant gene, as it's a closed barn--no new animals had been introduced for five decades. So how did it get there? "We don't know," Wittum told HealthDay News.
Wittum added that the researchers found "no evidence the pigs carried the gene into the [human] food supply."
The authors conclude:
The implication of our finding is that there is a real risk that CRE may disseminate in food animal populations and eventually contaminate fresh retail meat products. Food-borne transmission may then produce a reservoir of mobile carbapenemase genes in the enteric flora of consumers.
The Natural Resources Defense Council (NRDC) said the findings were troubling.
"The last terrible shoe may have just dropped when it comes to drug-resistant infections," said Dr. David Wallinga, senior health officer at NRDC.
"This is just one more warning that doctors may soon have nothing left in their toolkit to save patients when these bugs strike. Our overuse of antibiotics in livestock is creating reservoirs for the spread of resistance--and this study strongly suggests resistance to carbapenems is no exception. To save our miracle drugs, we have got to stop wasting them on animals that aren't sick," Wallinga added.
In September, when world leaders gathered for a historic high-level meeting at the United Nations General Assembly to lay out how to fight so-called "superbugs"--Dr. Margaret Chan, Director-General of the World Health Organization, said, "Antimicrobial resistance poses a fundamental threat to human health, development, and security. The commitments made today must now be translated into swift, effective, lifesaving actions across the human, animal and environmental health sectors."
"We are running out of time," she warned.

